BofA analyst George Staphos moves to No Rating on Pactiv given the stock is no longer trading on fundamentals following Apollo-owned Novolex having announced that the two packaging companies will combine with Pactiv shareholders receiving $18 per share in cash. The firm believes the stock is no longer trading on the basis of fundamentals, the analyst tells investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks